X

Trial Profile

A Multicenter Extension Trial of Subcutaneously Administered AIN457 in Participants With Moderate to Severe Chronic Plaque-type Psoriasis

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 14 Jan 2020

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Secukinumab (Primary)
Indications Plaque psoriasis
Focus Adverse reactions
Sponsors Novartis Pharmaceuticals

Most Recent Events

01 Mar 2017 This trial has been completed in Germany (End date:2016-10-18) as per European Clinical Trials Database record.
28 Feb 2017 Status changed from active, no longer recruiting to completed.
02 Aug 2016 Planned End Date changed from 1 May 2017 to 1 Nov 2017.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com